Department of Urology, Chinese People's Liberation Army General Hospital, Military Postgraduate Medical College, Beijing 100853, China.
Asian J Androl. 2013 Jul;15(4):513-7. doi: 10.1038/aja.2012.157. Epub 2013 May 27.
The aim of this study was to validate the advantages of the intrafascial nerve-sparing technique compared with the interfascial nerve-sparing technique in extraperitoneal laparoscopic radical prostatectomy. From March 2010 to August 2011, 65 patients with localized prostate cancer (PCa) underwent bilateral intrafascial nerve-sparing extraperitoneal laparoscopic radical prostatectomy. These patients were matched in a 1:2 ratio to 130 patients with localized PCa who had undergone bilateral interfascial nerve-sparing extraperitoneal laparoscopic radical prostatectomy between January 2008 and August 2011. Operative data and oncological and functional results of both groups were compared. There was no difference in operative data, pathological stages and overall rates of positive surgical margins between the groups. There were 9 and 13 patients lost to follow-up in the intrafascial group and interfascial group, respectively. The intrafascial technique provided earlier recovery of continence at both 3 and 6 months than the interfascial technique. Equal results in terms of continence were found in both groups at 12 months. Better rates of potency at 6 months and 12 months were found in younger patients (age ≤ 65 years) and overall patients who had undergone the intrafascial nerve-sparing extraperitoneal laparoscopic radical prostatectomy. Biochemical progression-free survival rates 1 year postoperatively were similar in both groups. Using strict indications, compared with the interfascial nerve-sparing technique, the intrafascial technique provided similar operative outcomes and short-term oncological results, quicker recovery of continence and better potency. The intrafascial nerve-sparing technique is recommended as a preferred approach for young PCa patients who are clinical stages cT1 to cT2a and have normal preoperative potency.
本研究旨在验证筋膜内神经保留技术相对于筋膜间神经保留技术在腹膜外腹腔镜根治性前列腺切除术的优势。2010 年 3 月至 2011 年 8 月,65 例局限性前列腺癌(PCa)患者接受双侧筋膜内神经保留的腹膜外腹腔镜根治性前列腺切除术。这些患者与 2008 年 1 月至 2011 年 8 月期间接受双侧筋膜间神经保留的腹膜外腹腔镜根治性前列腺切除术的 130 例局限性 PCa 患者按 1:2 比例匹配。比较两组的手术数据和肿瘤学及功能结果。两组在手术数据、病理分期和总阳性切缘率方面无差异。筋膜内组和筋膜间组分别有 9 例和 13 例失访。筋膜内技术在术后 3 个月和 6 个月时的控尿功能恢复均早于筋膜间技术。两组在 12 个月时的控尿效果相当。在 6 个月和 12 个月时,年轻患者(年龄≤65 岁)和总体患者的勃起功能恢复更好,这些患者接受了筋膜内神经保留的腹膜外腹腔镜根治性前列腺切除术。两组术后 1 年的生化无进展生存率相似。在严格的适应证下,与筋膜间神经保留技术相比,筋膜内神经保留技术在手术结果和短期肿瘤学结果方面相似,控尿功能恢复更快,勃起功能更好。筋膜内神经保留技术是临床分期 cT1 至 cT2a 且术前勃起功能正常的年轻 PCa 患者的首选方法。